Inventor
Grant Gallagher
Inventor
Milltown, NJ, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
C12NMicroorganisms or enzymes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07KPeptides15%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
H04NPictorial communication, e.g. television2%
PatentTitleYear
11,110,106Sting agonists for treating bladder cancer and solid tumors202110,416,172Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling201910,144,974Methods and reagents that specifically detect, distinguish and quantify IFN-LAMBDA2 mRNA from IFN-LAMBDA3 mRNA in humans20189,868,776'Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases'20189,850,489Repressor on IFN-l promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-l gene activity20179,605,027'Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof'20179,523,073'Elisa for a naturally-occurring soluble truncated form of IL-23 receptor'20169,506,066'Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activity'20169,464,321'Methods and reagents that specifically detect, distinguish and quantify IFN-λ2 mRNA from IFN-λ3 mRNA in humans'20169,187,750'Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases'20159,169,292'Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof'20159,163,238'Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity'20158,946,150'Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof'20158,933,049'Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity'20158,802,648'Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity'20148,771,666'Ex-vivo treatment of T-cells with IFN-λ'20148,618,070'Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases'20138,354,125'Ex-vivo treatment of peripheral blood leukocytes with IFN-λ'20138,349,808'Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity'20138,282,964'Ex-vivo treatment of peripheral plasmacytoid dendritic cells with IFN-lambda'20128,206,925'Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a delta 9 isoform in predicting inflammatory bowel diseases'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2019Patents assigned to GALLAGHER GRANT (15)· patent assignee history
2012–2015Patents assigned to MEDICAL DIAGNOSTIC LAB LLC (10)· patent assignee history
2012–2019Patents assigned to YU RAYMOND (9)· patent assignee history
2012–2021Based in Milltown, NJ, US· patent location history
2012Based in Hamilton, NJ, US· patent location history
2013–2019Patents assigned to BRAZAITIS JONATHAN (8)· patent assignee history
2016–2019Patents assigned to MEDICAL DIAGNOSTIC LABORATORIES LLC (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GALLAGHER GRANTself | 15 | 2012–2019 |
| MEDICAL DIAGNOSTIC LAB LLC | 10 | 2012–2015 |
| YU RAYMOND | 9 | 2012–2019 |
| BRAZAITIS JONATHAN | 8 | 2013–2019 |
| MEDICAL DIAGNOSTIC LABORATORIES LLC | 8 | 2016–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Milltown, New Jersey, US | 20 | 2012–2021 |
| Hamilton, New Jersey, US | 1 | 2012 |